References
- Tillotson GS. Where does novel antibiotics R&D stand among other pharmaceutical products: an industrial perspective? Expert Rev. Anti Infect. Ther.6(5), 551–552 (2008).
- Bad bugs no drugs. An update from the IDSA. Clin. Infect. Dis.48, 1–12 (2009).
- Payne DJ, Gwynn NM, Holmes DJ, Pompliano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov.6, 29–40 (2007).
Website
- GlaxoSmithKline’s pipeline chart www.gsk.com/investors/pp_pipeline_standard.htm
- ClinicalTrials.gov www.clinicaltrials.gov